Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 222

1.

Costs and benefits of polio eradication: a long-run global perspective.

Khan MM, Ehreth J.

Vaccine. 2003 Jan 30;21(7-8):702-5.

PMID:
12531344
2.

Retrospective cost-effectiveness analyses for polio vaccination in the United States.

Thompson KM, Tebbens RJ.

Risk Anal. 2006 Dec;26(6):1423-40.

PMID:
17184390
3.

Economic analysis of the global polio eradication initiative.

Duintjer Tebbens RJ, Pallansch MA, Cochi SL, Wassilak SG, Linkins J, Sutter RW, Aylward RB, Thompson KM.

Vaccine. 2010 Dec 16;29(2):334-43. doi: 10.1016/j.vaccine.2010.10.026. Epub 2010 Oct 26.

PMID:
21029809
4.

The cost-effectiveness of alternative polio immunization policies in South Africa.

Griffiths UK, Botham L, Schoub BD.

Vaccine. 2006 Jul 17;24(29-30):5670-8.

PMID:
16766096
5.

Cost analysis of post-polio certification immunization policies.

Sangrujee N, Cáceres VM, Cochi SL.

Bull World Health Organ. 2004 Jan;82(1):9-15. Epub 2004 Feb 26.

6.

Progress towards global polio eradication.

Hull HF.

Dev Biol (Basel). 2001;105:3-7.

PMID:
11763334
7.

The risks, costs, and benefits of possible future global policies for managing polioviruses.

Thompson KM, Tebbens RJ, Pallansch MA, Kew OM, Sutter RW, Aylward RB, Watkins M, Gary HE Jr, Alexander J, Jafari H, Cochi SL.

Am J Public Health. 2008 Jul;98(7):1322-30. doi: 10.2105/AJPH.2007.122192. Epub 2008 May 29.

8.

The global eradication of poliomyelitis: progress and problems.

Rey M, Girard MP.

Comp Immunol Microbiol Infect Dis. 2008 Mar;31(2-3):317-25. Epub 2007 Oct 17.

PMID:
17923156
9.

Economics of polio vaccination in the post-eradication era: should OPV-using countries adopt IPV?

Khan MM.

Vaccine. 2008 Apr 7;26(16):2034-40. doi: 10.1016/j.vaccine.2008.02.008. Epub 2008 Feb 22.

PMID:
18339460
10.

Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.

Zhou F, Santoli J, Messonnier ML, Yusuf HR, Shefer A, Chu SY, Rodewald L, Harpaz R.

Arch Pediatr Adolesc Med. 2005 Dec;159(12):1136-44.

PMID:
16330737
11.

Global Polio Eradication Initiative Strategic Plan, 2004.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2004 Feb 13;53(5):107-8.

12.

Progress toward global poliomyelitis eradication, 1999.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2000 Apr 28;49(16):349-54.

13.

Eradication versus control for poliomyelitis: an economic analysis.

Thompson KM, Tebbens RJ.

Lancet. 2007 Apr 21;369(9570):1363-71. Review.

PMID:
17448822
14.

Current status of polio eradication and future prospects.

Thacker N, Shendurnikar N.

Indian J Pediatr. 2004 Mar;71(3):241-5.

PMID:
15080411
15.

Rotary International: a partner in polio eradication.

Sever JL.

Dev Biol (Basel). 2001;105:105-8.

PMID:
11763319
16.

The costs of future polio risk management policies.

Tebbens RJ, Sangrujee N, Thompson KM.

Risk Anal. 2006 Dec;26(6):1507-31.

PMID:
17184394
17.

Poliomyelitis eradication: progress, challenges for the end game, and preparation for the post-eradication era.

Sutter RW, Tangermann RH, Aylward RB, Cochi SL.

Infect Dis Clin North Am. 2001 Mar;15(1):41-64. Review.

PMID:
11301822
18.

Infectious disease. Polio: no cheap way out.

Roberts L.

Science. 2007 Apr 20;316(5823):362-3. No abstract available.

PMID:
17446365
19.

Protecting investments in polio eradication: the past, present and future of surveillance for acute flaccid paralysis.

Heymann DL, De Gourville EM, Aylward RB.

Epidemiol Infect. 2004 Oct;132(5):779-80. No abstract available.

20.

Progress towards global polio eradication.

Hull HF, Aylward RB.

Vaccine. 2001 Aug 14;19(31):4378-84. Review.

PMID:
11483262
Items per page

Supplemental Content

Write to the Help Desk